Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter and Thermo Fisher to Help HHS Expand US Diagnostic Labs’ COVID-19 Testing Capacity

By LabMedica International staff writers
Posted on 19 Aug 2020
The US Department of Health and Human Services (HHS) will make combined investments of USD 6.5 million in two commercial diagnostic laboratories to expand their capacity for conducting up to four million additional SARS-CoV-2 tests per month.

The investments in Aegis Sciences Corporation (Nashville, TN, USA) and Sonic Healthcare USA (Austin, TX, USA) will provide critical laboratory equipment supplied by Beckman Coulter Life Sciences (Brea, CA, USA) and Thermo Fisher Scientific Inc. More...
(Waltham, MA, USA), and increase staffing and infrastructure to allow the US to perform an additional one million tests each week by early October.

In response to HHS investment, Aegis Sciences will rapidly expand its laboratory workforce and begin construction on new laboratory space at its testing facilities to meet its goal of processing more than 60,000 test samples per day beginning in September. With its expanded daily testing capacity, Aegis Sciences has agreed to partner with the Office of the Assistant Secretary for Health to perform testing of samples from select locations with vulnerable populations. These tests will return results in under 48 hours. Sonic Healthcare is collaborating closely with HHS to expeditiously ramp up their testing capacity at eight SARS-CoV-2 testing facilities. HHS will provide access to instrumentation and supplies necessary to rapidly expand the scope and expedite the timeline of their ongoing capacity expansion plans. The new testing capacity will significantly enhance patient access to SARS-CoV-2 diagnostic testing across the US.

Beckman Coulter will provide equipment that will enable laboratories to optimize their workflow, thereby increasing SARS-CoV-2 testing by up to 10,000 tests each day at 10 separate sites totaling an increase of 100,000 per day across the US. Thermo Fisher is supplying HHS with 56 KingFisher Flex extraction and purification systems and 40 QuantStudio 7 Flex Real-time polymerise chain reaction (PCR) tests. Each PCR test can run 384 samples at a time. These 96 systems which are capable of running more than 140,000 samples per day will be placed at the laboratories of Aegis Sciences and Sonic Healthcare around the US.

"We are committed to leveraging every possible opportunity to expand the nation's SARS-CoV-2 testing capacity over the next several months," said Assistant Secretary for Health ADM Brett Giroir, M.D. "For this opportunity, we were able to match available instrumentation and reagents with commercial labs that were ready to immediately expand their services. We are honored to work with these labs and life sciences tools companies to ensure increased access to testing as may be needed this fall."

Related Links:

Aegis Sciences Corporation
Sonic Healthcare USA
Beckman Coulter Life Sciences
Thermo Fisher Scientific Inc.

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.